Key questions in COVID-19 are the duration and determinants of infectious virus shedding.
Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 …

Objective: The HepatAssist liver support system is an extracorporeal porcine hepatocyte-based
bioartificial liver (BAL). The safety and efficacy of the BAL were evaluated in a prospective…

Background Long-term shedding of viral RNA in COVID-19 prevents timely discharge from
the hospital or de-escalation of infection prevention and control practices. Key questions are …

Short-term patient and graft outcomes continue to improve after kidney and liver transplantation,
with 1-year survival rates over 80%; however, improving longer-term outcomes remains …

Intravenous immunoglobulin (IVIg) is therapeutically used in a variety of immune-mediated
diseases. The beneficial effects of IVIg in auto-antibody-mediated diseases can be explained …

Recent animal and human studies have highlighted the potential of hepatocyte‐derived
microRNAs (HDmiRs) in serum as early, stable, sensitive, and specific biomarkers of liver injury. …

Background & Aims Frail patients with low model for end-stage liver disease (MELD) scores
may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been …

Background & Aims Many recipients of organ transplants develop chronic hepatitis, due to
infection with the hepatitis E virus (HEV). Although chronic HEV infection is generally …

BACKGROUND: Optimal management in patients with umbilical hernias and liver cirrhosis
with ascites is still under debate. The objective of this study was to compare the outcome in …

Despite the introduction of oral vaccines, rotavirus still kills over 450,000 children under five
years of age annually. The absence of specific treatment prompts research aiming at further …